{"abstract":"The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of July 15, 2020. In that notice, FDA requested comments on draft guidance for industry (GFI) #61 entitled \"Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species.\" FDA is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.","action":"Notice of availability; extension of comment period.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/11/10/2020-24970.html","cfr_references":[],"citation":"85 FR 71659","comment_url":null,"comments_close_on":"2021-01-11","correction_of":null,"corrections":[],"dates":"FDA is extending the comment period announced in the notice of availability published July 15, 2020 (85 FR 42876). Submit either electronic or written comments by January 11, 2021, to ensure that the Agency considers your comments on this draft guidance before it begins work on the final version of the guidance.","disposition_notes":null,"docket_ids":["Docket No. FDA-1997-D-0444"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":12,"comment_start_date":"2020-11-10","updated_at":"2023-02-28T22:38:46.162-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-1997-D-0444-0021","allow_late_comments":null,"id":"FDA-1997-D-0444-0021","comment_end_date":"2021-01-12","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-1997-D-0444","title":"Guidance of Animal Drugs for Minor Uses & Minor Species"}],"document_number":"2020-24970","effective_on":null,"end_page":71660,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/11/10/2020-24970.xml","html_url":"https://www.federalregister.gov/documents/2020/11/10/2020-24970/special-considerations-incentives-and-programs-to-support-the-approval-of-new-animal-drugs-for-minor","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-24970?publication_date=2020-11-10","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-11-10/2020-24970/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":332,"last_updated":"2026-09-21 12:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-11-10/pdf/2020-24970.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-24970.pdf?1604929534","publication_date":"2020-11-10","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/11/10/2020-24970.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":12,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-1997-D-0444","supporting_documents_count":0,"docket_id":"FDA-1997-D-0444","document_id":"FDA-1997-D-0444-0021","regulation_id_number":null,"title":"Guidance of Animal Drugs for Minor Uses & Minor Species","checked_regulationsdotgov_at":"2023-03-01T03:38:45Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":71659,"subtype":null,"title":"Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Draft Guidance for Industry; Availability; Extension of Comment Period","toc_doc":"Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":85}